Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States and in Canada. It is testing seroquel Plus Mood Stabilizer for Bipolarity.
In United StatesThis study is completed in the United States. 25 mg for ADHD.
In United StatesThis study is completed in the United States. It is testing SPD503 for ADHD.
In United StatesThis study is completed in the United States. It is testing SPN-812 (Viloxazine Extended-release Capsule) for ADHD.
In United StatesThis study is completed in the United States. It is testing topiramate for Eating disorders.
In United StatesThis study is completed in the United States and in Spain. It is testing TV-1380 for Addiction.
In United StatesThis study is completed in the United States, in India, and in Romania. It is testing two Atypical Antipsychotics for schizophrenia.
In United StatesThis study is completed in the United States. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It is testing troriluzole for OCD.
In United StatesThis study is completed in the United States. It is testing BHV-7000 Monotherapy for depression.
In United StatesThis study was terminated in the United States. It is testing clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo for schizophrenia.
In United StatesThis study was terminated in the United States and in Mexico. It is testing Low-Dose Ondansetron for OCD.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.